Skip to main content
. 2020 Oct 15;7:576925. doi: 10.3389/fmed.2020.576925

Table 3.

Characteristics of lower calyx stone patients in the primary and validation cohorts.

Primary cohort Validation cohort
SF Non-SF p SF Non-SF p
Number of patients, n 56 43 24 19
Age, mean ± SD, years 50.34 ± 10.82 48.40 ± 12.31 0.406a 49.71 ± 12.94 49.89 ± 11.55 0.961a
Gender, n (%) 0.350 0.553
Male 34 (53.1%) 30 (46.9%) 11 (61.1%) 7 (38.9%)
Female 22 (62.9%) 13 (37.1%) 13 (52.0%) 12 (48.0%)
BMI, mean ± SD, kg m−2 24.64 ± 3.75 23.15 ± 3.76 0.136a 23.71 ± 3.24 24.12 ± 3.20 0.754a
Stone laterality, n (%) 0.056 0.759
Left 27 (48.2%) 29 (51.8%) 15 (57.7%) 11 (42.3%)
Right 29 (67.4%) 14 (32.6%) 9 (52.9%) 8 (47.1%)
Hydronephrosis <0.001 <0.001
No/mild 46 (78.0%) 13 (22.0%) 20 (83.3%) 4 (16.7%)
Severe 10 (25.0%) 30 (75.0%) 4 (21.1%) 15 (78.9%)
Experience of operator, n (%) <0.001 0.001
fURS ≥ 100 40 (78.4%) 11 (21.6%) 17 (81.0%) 4 (19.0%)
fURS < 100 16 (33.3%) 32 (66.7%) 7 (31.8%) 15 (68.2%)
Stone diameter (cm), n (%) 0.007 0.012
≤ 1 42 (66.7%) 21 (33.3%) 18 (72.0%) 7 (28.0%)
>1 14 (38.9%) 22 (61.1%) 6 (33.3%) 12 (66.7%)
Stone volume (cm3), n (%) <0.001 0.002
≤ 1 49 (71.0%) 20 (29.0%) 19 (76.0%) 6 (24.0%)
>1 7 (23.3%) 23 (76.7%) 5 (27.8%) 13 (72.2%)
Radiomics score, median (interquartile range) 1.348 (0.467–2.243) −0.462 (−1.429 to 0.260) <0.001b 0.557 (−0.175 to 2.009) −0.895 (−1.482 to −0.119) <0.001b

SD, standard deviation; fURS, flexible ureteroscope; SF, stone free.

a

t-test.

b

rank sum test.

Others are chi-square test.